FDA Adverse Event Injury Summary report: N

RELAY PRO THORACIC STENT-GRAFT SYSTEM

MDR report key: 17736219 · Received September 13, 2023

Report

Report Number
2247858-2023-00240
Event Type
Injury
Date Received
September 13, 2023
Date of Event
August 22, 2023
Report Date
October 11, 2023
Manufacturer
BOLTON MEDICAL INC.
Product Code
MIH
PMA / PMN Number
P200045
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

BOLTON MEDICAL, INC. (D/B/A TERUMO AORTIC), HEREIN KNOWN AS THE "COMPANY", IS SUBMITTING THIS REPORT PURSUANT TO 21 CFR PART 803, HAS MADE REASONABLE EFFORTS TO OBTAIN COMPLETE INFORMATION, AND HAS PROVIDED AS MUCH AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT IS BASED ON INFORMATION OBTAINED BY THE COMPANY, WHICH MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE REGULATIONS. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN, UNAVAILABLE, OR NOT APPLICABLE. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY ANYONE THAT THE DEVICE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE A LEGAL ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY DEFECTS OR HAS MALFUNCTIONED, AS DEFINED FROM A LEGAL STANDPOINT. THESE WORDS ARE INCLUDED IN THE REPORT AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE CERTAIN REGULATIONS, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT.

Additional Manufacturer Narrative · 0

BOLTON MEDICAL, INC. (D/B/A TERUMO AORTIC), HEREIN KNOWN AS THE "COMPANY", IS SUBMITTING THIS REPORT PURSUANT TO 21 CFR PART 803, HAS MADE REASONABLE EFFORTS TO OBTAIN COMPLETE INFORMATION, AND HAS PROVIDED AS MUCH AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT IS BASED ON INFORMATION OBTAINED BY THE COMPANY, WHICH MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE REGULATIONS. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN, UNAVAILABLE, OR NOT APPLICABLE. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY ANYONE THAT THE DEVICE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE A LEGAL ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY DEFECTS OR HAS MALFUNCTIONED, AS DEFINED FROM A LEGAL STANDPOINT. THESE WORDS ARE INCLUDED IN THE REPORT AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE CERTAIN REGULATIONS, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT.

Description of Event or Problem · 0

"ENDOLEAK (TYPE IA) INTO THE FALSE LUMEN: A RELAYPRO STENT-GRAFT (28-N4-28-104-28U, LOT# 2208020273) WAS IMPLANTED ON THE DISTAL SIDE, AND THE RELAYPRO STENT-GRAFT (28-N4-34-154-30U, LOT# 2301240067) CONCERNED WAS THEN IMPLANTED ON THE PROXIMAL SIDE. DURING FINAL ANGIOGRAPHY, A TYPE IA ENDOLEAK INTO THE FALSE LUMEN OCCURRED. THE PROCEDURE WAS COMPLETED WITHOUT ADDITIONAL TREATMENT DUE TO THE PATIENT WITH A DISSECTION. INFORMATION ON THE PATIENT'S POSTOPERATIVE CONDITION WILL BE OBTAINED LATER. OPERATION TYPE: TEVAR. NO BLOOD LOSS. ANCILLARY DEVICE USED: DRYSEAL INTRODUCER SHEATH (22 FR, GORE), LUNDERQUIST EXTRA STIFF GUIDEWIRE (0.035 INCHES, 300 CM, COOK MEDICAL). MEDICATIONS USED: HEPARIN, PROTAMINE. IMAGE WILL BE AVAILABLE. PRE-CASE PLAN WILL BE AVAILABLE. ADDITIONAL INFORMATION WILL BE ABLE TO BE OBTAINED. (TC#(B)(4))."PATIENT OUTCOME - "THE PATIENT'S CONDITION IS UNKNOWN AND WILL BE UPDATED. ADDITIONAL INFORMATION OBTAINED ON SEPTEMBER 07, 2023: -THROMBOSIS HAS PROGRESSED ONE DAY AFTER THE PROCEDURE. THE PHYSICIAN EXPECTS THAT THIS TO ELIMINATE THE ENDOLEAK. CT SCAN IS SCHEDULED AGAIN IN THREE MONTHS. NO OTHER IMAGE INFORMATION CAN BE PROVIDED."

Description of Event or Problem · 0

"ENDOLEAK (TYPE IA) INTO THE FALSE LUMEN: A RELAYPRO STENT-GRAFT (28-N4-28-104-28U, LOT# 2208020273) WAS IMPLANTED ON THE DISTAL SIDE, AND THE RELAYPRO STENT-GRAFT (28-N4-34-154-30U, LOT# 2301240067) CONCERNED WAS THEN IMPLANTED ON THE PROXIMAL SIDE. DURING FINAL ANGIOGRAPHY, A TYPE IA ENDOLEAK INTO THE FALSE LUMEN OCCURRED. THE PROCEDURE WAS COMPLETED WITHOUT ADDITIONAL TREATMENT DUE TO THE PATIENT WITH A DISSECTION. *INFORMATION ON THE PATIENT'S POSTOPERATIVE CONDITION WILL BE OBTAINED LATER. OPERATION TYPE: TEVAR. NO BLOOD LOSS. ANCILLARY DEVICE USED: DRYSEAL INTRODUCER SHEATH (22 FR, GORE), LUNDERQUIST EXTRA STIFF GUIDEWIRE (0.035 INCHES, 300 CM, COOK MEDICAL). MEDICATIONS USED: HEPARIN, PROTAMINE. IMAGE WILL BE AVAILABLE. PRE-CASE PLAN WILL BE AVAILABLE. ADDITIONAL INFORMATION WILL BE ABLE TO BE OBTAINED (TC#(B)(4). PATIENT OUTCOME - "THE PATIENT'S CONDITION IS UNKNOWN AND WILL BE UPDATED. ADDITIONAL INFORMATION OBTAINED ON SEPTEMBER 07, 2023: - THROMBOSIS HAS PROGRESSED ONE DAY AFTER THE PROCEDURE. THE PHYSICIAN EXPECTS THAT THIS TO ELIMINATE THE ENDOLEAK. - CT SCAN IS SCHEDULED AGAIN IN THREE MONTHS. - NO OTHER IMAGE INFORMATION CAN BE PROVIDED."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1614915 RELAY PRO THORACIC STENT-GRAFT SYSTEM STENT, ENDOVASCULAR GRAFT, AORTIC MIH BOLTON MEDICAL INC. 2301240067

Patients

Seq Age Sex Outcome Treatment
1 62 YR Male Other